Ferozsons Laboratories Limited reported a net profit of Rs 503.87 million for the nine months ended 31 March 2026
Filed as: Financial Results for the Quarter Ended 31-03-2026
Summary
Ferozsons Laboratories Limited reported a net profit of Rs 503.87 million for the nine months ended 31 March 2026, reflecting a growth in revenue to Rs 11.95 billion. However, cash flow from operations decreased significantly.
Read the original filingFigures in the filing
| Item | This period | Period before | Change |
|---|---|---|---|
| Revenue | PKR 11.95 billion | PKR 10.81 billion | +10.5% |
| Net Profit After Taxation | PKR 503.87 million | PKR 390.44 million | +29.1% |
| Cash Generated from Operations | PKR 630.86 million | PKR 1,521.70 million | -58.5% |
| Earnings Per Share (EPS) | PKR 11.59 | PKR 8.98 | +29.1% |
| Gross Profit | PKR 4.99 billion | PKR 4.29 billion | +16.3% |
Amounts are in Pakistani rupees as stated in the filing (M = million, B = billion).
What the filing says
- Revenue increased to Rs 11.95 billion from Rs 10.81 billion, a growth of 10.52% compared to the prior period.
- Net profit after taxation rose to Rs 503.87 million from Rs 390.44 million, marking a 29.06% increase.
- Cash generated from operations decreased to Rs 630.86 million from Rs 1,521.70 million, indicating a significant decline in operational cash flow.
Ferozsons Laboratories Limited (FEROZ) on Nafa
Last price Rs 364.02 · Pharmaceuticals · You can own FEROZ shares from your phone.
More FEROZ announcements
- NoticeCredit of final cash dividend
- NoticeChange of Company Secretary
- NoticeCompany Secretary
- NoticeTransmission of Quarterly Financial Statements for the Period Ended 30-09-2026
- Financial resultFerozsons Laboratories Limited reported a strong performance for the first quarter ended 30 September 2026Filed as: Financial Results for the Quarter Ended 30-09-2026
- NoticeCertified True Copies of the Resolutions passed at the 70th Annual General Meeting of the Company
Source: Ferozsons Laboratories Limited's filing with the Pakistan Stock Exchange. The summary and figures on this page are extracted from the filing by software and can contain errors; the filing itself is the record. This page describes the filing. It is not investment advice and Nafa does not recommend any stock. Investing in securities involves risk, including possible loss of principal.